LT - GLYX FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE, PARKINSON'S DISEASE OR HUNTINGTON'S DISEASE
EN - GLYX FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE, PARKINSON'S DISEASE OR HUNTINGTON'S DISEASE
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
| (51) |
INT.CL. |
A61K 38/10 |
(2006.01) |
|
|
A61P 25/22 |
(2006.01) |
|
|
A61P 25/24 |
(2006.01) |
Europos patentas
| (11) |
Patento numeris |
2985032 |
| (13) |
Dokumento rūšis |
T |
| (96) |
Europos patento paraiškos numeris |
15171991.1 |
|
Europos patento paraiškos padavimo data |
2010-10-05 |
| (97) |
Europos patento paraiškos paskelbimo data |
2016-02-17 |
| (45) |
Paskelbimo apie Europos patento išdavimą data |
2019-01-02
|
| (46) |
Apibrėžties vertimo paskelbimo data |
|
Prioriteto paraiškos
| (30) |
Numeris |
Data |
Šalis |
|
248650 P |
2009-10-05
|
US |
Išradėjai
| (72) |
MOSKAL, Joseph, US
|
Savininkas
| (73) |
Northwestern University,
633 Clark Street, Evanston, IL 60208,
US
|
Pavadinimas
| (54) |
GLYX FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE, PARKINSON'S DISEASE OR HUNTINGTON'S DISEASE |
| |
GLYX FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE, PARKINSON'S DISEASE OR HUNTINGTON'S DISEASE |
